Invention Grant
- Patent Title: Anti-androgens for the treatment of metastatic castration-sensitive prostate cancer
-
Application No.: US18168204Application Date: 2023-02-13
-
Publication No.: US11963952B2Publication Date: 2024-04-23
- Inventor: Margaret K. Yu
- Applicant: ARAGON PHARMACEUTICALS, INC.
- Applicant Address: US CA Los Angeles
- Assignee: Aragon Pharmaceuticals, Inc.
- Current Assignee: Aragon Pharmaceuticals, Inc.
- Current Assignee Address: US CA Los Angeles
- Agency: BakerHostetler
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; A61K31/4155 ; A61K31/4166 ; A61P5/28 ; A61P35/00
Abstract:
Described herein are methods of treating metastatic castration-sensitive prostate cancer with anti-androgens, including but not limited to, 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide.
Public/Granted literature
- US11903937B2 Anti-androgens for the treatment of metastatic castration-sensitive prostate cancer Public/Granted day:2024-02-20
Information query
IPC分类:
